These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2841046)

  • 41. Transformation of human cells by oncogenic viruses supports permissiveness for parvovirus H-1 propagation.
    Faisst S; Schlehofer JR; zur Hausen H
    J Virol; 1989 May; 63(5):2152-8. PubMed ID: 2495371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Replication process of the parvovirus H-1. IV. H-1-specific proteins synthesized in synchronized human NB kidney cells.
    Kongsvik JR; Gierthy JF; Rhode SL
    J Virol; 1974 Dec; 14(6):1600-3. PubMed ID: 4372413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antineoplastic activity of parvoviruses.
    Rommelaere J; Cornelis JJ
    J Virol Methods; 1991 Aug; 33(3):233-51. PubMed ID: 1783673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth and isotopic labelling of adherent cells in small volumes of medium.
    Vultur A; Keiski CL; Maynard M; Grammatikakis N; Raptis L
    J Virol Methods; 2002 Mar; 101(1-2):207-10. PubMed ID: 11849699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell characterization by use of multiple genetic markers.
    Hukku B; Halton DM; Mally M; Peterson WD
    Adv Exp Med Biol; 1984; 172():13-31. PubMed ID: 6328905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoplastic transformation-associated stimulation of the in vitro resolution of concatemer junction fragments from minute virus of mice DNA.
    Kuntz-Simon G; Bashir T; Rommelaere J; Willwand K
    J Virol; 1999 Mar; 73(3):2552-8. PubMed ID: 9971842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose-dependent induction of resistance to terminal differentiation in x-irradiated cultures of normal human keratinocytes.
    Tuynder M; Godfrine S; Cornelis JJ; Rommelaere J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2638-42. PubMed ID: 2011575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1.
    Chen YQ; de Foresta F; Hertoghs J; Avalosse BL; Cornelis JJ; Rommelaere J
    Cancer Res; 1986 Jul; 46(7):3574-9. PubMed ID: 3011251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    Fresa KL; Karjalainen HE; Tevethia SS
    J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fate and expression of simian virus 40 DNA after introduction into murine cells under nonselective conditions.
    Brockman WW; Christensen JB; Ryan KW; Souwaidane M; Imperiale MJ
    Virology; 1987 May; 158(1):118-25. PubMed ID: 3033884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human glioblastoma cells persistently infected with simian virus 40 carry nondefective episomal viral DNA and acquire the transformed phenotype and numerous chromosomal abnormalities.
    Norkin LC; Steinberg VI; Kosz-Vnenchak M
    J Virol; 1985 Feb; 53(2):658-66. PubMed ID: 2578579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host range analysis of simian virus 40, BK virus and chimaeric SV40/BKV: relative expression of large T-antigen and Vp1 in infected and transformed cells.
    O'Neill FJ; Carney H; Hu Y
    Dev Biol Stand; 1998; 94():191-205. PubMed ID: 9776240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positive selection of human cells lacking several transformation parameters from an SV40-transformed culture by means of parvovirus H-1.
    Su ZZ; Luo ZY; Guo LP; Dupont F; Avalosse B; Rommelaere J
    Carcinogenesis; 1988 Aug; 9(8):1395-400. PubMed ID: 2841046
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.